Context: Uncontrolled hypertension remains a widely prevalent cardiovascular risk factor in the U.S. team-based care, established by adding new staff or changing the roles of existing staff such as nurses and pharmacists to work with a primary care provider and the patient. Team-based care has the potential to improve the quality of hypertension management. The goal of this Community Guide systematic review was to examine the effectiveness of team-based care in improving blood pressure (BP) outcomes.
H ypertension, defined as having systolic blood pressure (SBP) Z140 mmHg or diastolic blood pressure (DBP) Z90 mmHg at two or more office visits or current use of BP-lowering medications, 1, 2 remains the predominant risk factor for cardiovascular mortality in the U.S. 3, 4 The prevalence of hypertension among U.S. adults (aged Z18 years) from 2003 to 2010 was 30.4%-approximately 66.9 million adults. 5 Estimated annual costs of hypertension are $93.5 billion per year 1 and are projected to increase to $130.4 billion in 2030 if the status quo is maintained. 6 Because 90% of adults with uncontrolled hypertension have a usual source of health care with insurance coverage, improving the quality of care for high BP is a priority, as reflected in the Healthy People 2020 objectives. 5, 7 Interventions aimed at improving hypertension care need to target both provider-related and patient-related barriers in order to accrue health benefits at the population level. 1, 8, 9 One way is through innovative care delivery models such as the Chronic Care Model 10, 11 and the Patient-centered Medical Home (PCMH), 12 which attempt to deliver effective interventions to all patients. 13 A key feature of these care models is the incorporation of a multidisciplinary team for delivery of healthcare services. This team-based approach organizes care around patients' needs and is frequently implemented with systems support for clinical decision making, collaboration, and patient self-management. [10] [11] [12] Teambased care provides opportunities for care to be more patient centered by being more personalized, timely, collaborative, and empowering while also allowing providers more time to manage complex and critical issues. 14 Previous systematic reviews have found team-based care to be effective in improving BP outcomes. [15] [16] [17] Building on that foundation, this Community Guide systematic review examined current evidence on the effectiveness of team-based care in improving BP outcomes and the applicability of findings to various U.S. populations and settings using methods developed for The Community Guide. 18, 19 Important implementation aspects, such as the type of team member added and role of team members related to medication management, were evaluated, as was the potential benefit of team-based care extending to other cardiovascular disease (CVD) risk factors, such as high cholesterol and diabetes.
Evidence Acquisition
Systematic review methods used by The Community Guide can be found at www.thecommunityguide.org/about/methods.html. 18, 19 For this review, a coordination team was constituted, including subject matter experts on CVD from various agencies, organizations, and institutions together with qualified systematic reviewers from The Community Guide. The team worked under the oversight of the Community Preventive Services Task Force.
Conceptual Approach and Analytic Framework
The coordination team defined team-based care as adding new staff or changing the roles of existing staff to work with a primary care provider. Each team includes the patient, the patient's primary care provider, and other professionals such as nurses, pharmacists, dietitians, social workers, and community health workers. These professionals complement the activities of the primary care provider by providing process support and sharing the responsibilities of hypertension care, which include medication management, active patient follow-up, and adherence and selfmanagement support. Team-based care aims to facilitate communication and coordination of care support among various team members; enhance use of evidence-based guidelines by providers; establish regular, structured follow-up mechanisms to monitor patients' progress and schedule additional visits as needed; and actively engage patients in their own care by providing them with education about hypertension medication, adherence support (for medication and other treatments), and tools and resources for selfmanagement (including health behavior change).
Organizing health system staff such as primary care providers, pharmacists, and nurses to work with patients diagnosed with hypertension leads to better patient support, team member collaboration, and quality of hypertension care. This organizational change is expected to improve outcomes for BP, CVD morbidity and mortality, patient-centered outcomes such as satisfaction with care and treatment adherence, and comorbid CVD risk factors such as diabetes and high cholesterol. Systems-level support, such as use of electronic health records, clinical decision support, and surveillance, frequently accompany team-based care efforts ( Figure 1 ).
Search for Evidence
The search for evidence consisted of two steps ( Figure 2 ).
Step 1 involved locating existing systematic reviews on team-based care for BP control. Although multiple high-quality systematic reviews on this topic were identified, [15] [16] [17] the systematic review by Walsh and colleagues 17 had a conceptualization and methods similar to the Community Guide approach. 18, 19 Further, the scope adopted for the Walsh review reflected the team's goal of examining the effectiveness of team-based care from a population health perspective. The literature search from this prior review 17 ended in July 2003.
Step 2 consisted of an updated search adopting the Walsh review's search terms and databases. 17 This Community Guide update covered the period from July 2003 to May 2012. The complete search strategy is available at www.thecommunityguide.org/cvd/supportingmateri als/SS-team-based-care.html. The remainder of this section discusses the methodology for the Community Guide review.
Inclusion Criteria
Studies were included if they met the definition of team-based care as described in the conceptual framework; were in English; were not in the Walsh et al. 17 review;
were conducted in a high-income economy 20 consistent with Community Guide methods; reported at least one BP outcome of interest (i.e., proportion of patients with controlled BP, reduction in SBP, or reduction in DBP); included a comparison group or had an interrupted time-series design with at least two measurements before and after the intervention; targeted populations with primary hypertension or populations with comorbid conditions such as diabetes as long as the primary focus of the intervention was BP control; and did not include populations with secondary hypertension (e.g., pregnancy) or with a history of CVD (e.g., myocardial infarction).
Data Abstraction and Quality Assessment
Each study included in the current review was evaluated independently by two reviewers. Abstraction was based on the standard Community Guide process (www.thecommunityguide.org/meth ods/abstractionform.pdf). Disagreements between reviewers were resolved by consensus.
Using Community Guide methods, each study was assessed for threats to internal and external validity. 18 Threats to validity-such as poor descriptions of the intervention, population, sampling frame, and inclusion/exclusion criteria; poor measurement of exposure or outcome; lack of appropriate analytic methods; incomplete data sets; high attrition; or intervention and comparison groups not being comparable at baseline-were used to characterize studies as having good (0-1 limitations); fair (2-4); or limited (44) quality of execution. Studies judged to be of limited quality of execution were excluded from analysis.
Conclusions on the strength of evidence on effectiveness are based on evidence from both reviews (Walsh and colleagues 17 and this Community Guide update), taking into account the number of studies, quality of available evidence, consistency of results, magnitude of effect estimates, and applicability considerations. 18 
Primary Outcomes of Interest
Three BP-related outcomes were the primary variables used to determine intervention effectiveness: proportion of patients with controlled BP and reduction of SBP and DBP (Figure 1 ). CVDrelated morbidity (e.g., incidence of heart attacks and strokes) and mortality were also considered primary outcomes, if available.
Proportion of patients with controlled BP. The minimum requirements for this outcome were established standards for BP control (o140/90 mmHg or o130/80 mmHg for people with diabetes). 2 Using data from the last available time point with ongoing team-based care, the absolute percentage point change in the proportion of patients receiving team-based care achieving BP control compared to patients in usual care was calculated for each study. An intent-to-treat analysis method was adopted wherein patients in both intervention and usual care groups that did not complete followup were considered to have uncontrolled BP. For a study with multiple team-based care intervention arms, a single effect estimate was calculated comparing the combined data from all intervention arms to usual care.
Reduction in SBP and DBP. For each study, the differencein-differences of mean SBP or DBP was calculated based on the last time point measured while the intervention was in progress for patients receiving team-based care compared to patients For the overall summary measure, the median of effect estimates from individual studies with the interquartile interval (IQI) was reported for each BP outcome.
Secondary Outcomes
Outcomes from one additional area were also analyzed when reported in included studies: patient-oriented outcomes, including medication adherence and satisfaction with care. Calculation of study-level and summary effect estimates followed the same methods as those for BP outcomes with comparable metrics, using proportions for dichotomous variables and means for continuous variables.
Evidence Synthesis
The existing systematic review by Walsh et al. 17 (Figure 2 ). Both reviews indicated that team-based care resulted in substantial improvements in all BP outcomes ( Table 1 ). The remainder of this paper provides detailed results from analysis of the 52 studies in the current Community Guide review.
Study and Intervention Characteristics
Limitations identified in the included studies showed significant differences in patient demographics between intervention and comparison groups at baseline, possible contamination within intervention and comparison groups, and issues related to inadequate description of populations and implemented interventions (Figure 3) .
Thirty-eight studies were conducted in the U.S. 
Population Characteristics
Study populations included adults and older adults and were balanced across gender (Table 2) . For most studies, the majority of patients were either white or African American. Eight studies 21, 22, 32, 34, 38, 41, 50, 58 focused predominantly on populations where 450% of participants identified as low-income. In studies providing information on education level, the majority of participants identified as having a high school education or less. 21, 22, 25, 26, 30, 32, 34, 38, 48, 50, 54, 58 In six studies, 36, 38, 41, 42, 50, 58 more than half the population received either Medicare or Medicaid or were uninsured. In almost all Additional evidence. Owing to differences in reporting, three studies could not be included in the main analyses. 32, 40, 97 One study 40 found that groups receiving teambased care had poorer BP outcomes than those receiving usual care (p40.05). Another study 32 found highincome patients significantly more likely to have BP control with team-based care (po0.05), and the third 97 reported slight improvements in BP control (p¼0.23) and SBP (p¼0.12) and no change in DBP (p¼0.37) for patients receiving home health visits.
Stratified Analyses for BP Outcomes
Setting. Improvement in the proportion of patients with controlled BP was similar for studies from both healthcare and community settings. The median effect estimate from studies within the Veterans Affairs (VA) system 25,27,33,43,47,51,74,96 was 5.9 pct pts; an investigator involved in two VA studies 25, 27 postulated (H. Bosworth, Duke University School of Medicine, personal communication, 2012) that this lower number is likely due to elements of team-based care already instituted in usual care processes at the VA and high baseline levels of patients with controlled BP. Median reductions in SBP and DBP from these studies were similar to overall estimates (Table 3) . Type of team member added. When pharmacists were added to teams, the median improvement in the proportion of patients with controlled BP was considerably higher than the overall estimate, but median reductions in SBP and DBP were similar to overall estimates (Table 3 ). When nurses alone or both nurses and pharmacists were added, median estimates for all BP outcomes were comparable to overall estimates. Only four studies 24, 48, 58, 69 examined the effectiveness of adding other team members, such as community health workers, integrated care managers, or behavioral interventionists without nurses or pharmacists, finding smaller effect estimates than those overall.
Type of team member role related to medication. Team member involvement in medication management was conceptualized as three levels: (1) team members could make changes to medications independent of the primary care provider (16 studies) 21 95 One study examined multiple levels of team member roles using multiple study arms. 27 The first two levels of medication management demonstrated larger improvements in BP outcomes than overall estimates (Table 3) .
Number of team members added. Thirty-three interventions 22, [24] [25] [26] [27] [28] [30] [31] [32] 37, 39, 40, [42] [43] [44] 47, 49, 51, 52, [54] [55] [56] [57] [58] 61, 64, 65, 68, [71] [72] [73] [74] [75] included one team member in addition to the primary care provider, 11 21, 23, 27, 29, 38, 44, 48, 53, 62, 69, 76 had two additional members, and 10 33, 34, 36, 41, 45, 50, 63, [95] [96] [97] involved three or more. Two studies 27, 44 with multiple study arms had different numbers of team members in each arm. Adding two or more members demonstrated larger improvements in the proportion of patients with controlled BP and reduction in DBP compared to adding only one; median reductions in SBP were similar regardless of team size (Table 3) .
Baseline BP level. Fifteen studies 22, 30, 31, 33, 37, 42, 44, 51, 52, 56, 57, 62, 68, 76, 97 focused exclusively on patients with uncontrolled BP at baseline. In 14 studies, 23, 25, 28, 41, 43, [48] [49] [50] 53, 54, 71, 75, 95, 96 r50% of the patients had controlled BP at baseline. Larger improvements in this outcome were found for these two groups compared to studies 26, 27, 39, 61, 69 average SBP Z140 mmHg at baseline had a greater reduction in SBP than those where the average SBP was o140 mmHg at baseline. This trend was also seen in six studies 41, 42, 44, 52, 62, 73 that had an average DBP reading Z90 mmHg at baseline (Table 3 ).
Morbidity and Mortality
Two studies reported on morbidity and mortality from CVD-related events. One 29 found significant decreases in both myocardial infarctions and any CVD-related event (OR¼0.24 and 0.47, respectively, po0.05). Another study 57 found that the team-based care group had 25 deaths compared to 36 deaths in the control group (OR¼0.55, po0.05) after 12 months.
Medication Adherence and Patient Satisfaction with Care
Compared with patients in usual care, the proportion of patients receiving team-based care with "high" medication adherence (defined as taking medications as prescribed 480% of the time) increased by a median of 16.3 pct pts. 24, 32, 33, 42, 47, 51, 52, 54, 76 Two studies 42, 45 reported "satisfaction with care" at 12 months. In one study, 42 high patient satisfaction scores were seen for hypertension care in both the team-based and usual care groups (p¼0.75) with no significant association between satisfaction and BP goal achievement (p¼0.40). The other study, 45 comparing a team-based care approach that focused on diabetes, heart disease, or both with usual care, found an improvement of 14.0 pct pts in the proportion of patients reporting satisfaction with care (po0.001).
Applicability of Findings
Findings from this review are applicable to the U.S. healthcare system in both clinic-and community-based settings, especially when nurses and pharmacists are part of the team. Larger improvements in BP were found when team members could prescribe medications independent of the primary care provider or with their approval. However, improvements were also found when team members could only provide patients with hypertension information and support, indicating applicability to all levels of medication management.
White and African American populations were well represented across the included studies. Findings should be broadly applicable to various populations and settings in the U.S. Team-based care models are likely applicable in addressing BP control in patients with comorbidities such as diabetes: nine studies 33, 49, 53, 56, 57, 68, 72, 74, 95 targeted BP control in people with diabetes and four studies 45, 50, 51, 97 had study populations in which the majority also had diabetes. No harm to patients were identified from team-based care interventions in the included studies or the broader literature. Team-based care is well suited to addressing potential adverse effects from hypertension medications through providing support for patients about medications as well as proactive follow-up and monitoring.
Considerations for Implementation
Team-based care implementation must be considered at multiple overlapping levels. In most U.S. health systems, successful implementation will likely require reorganization of patient care roles and responsibilities. An important consideration is resource allocation to support providers who implement team-based care. Reimbursement mechanisms need to support key elements that sustain benefits from team-based care. These include incentives for improving patient outcomes, training, performance feedback, clinical decision support systems, and communications support.
Findings suggest that team member roles that allow for changes to medication regimens using evidence-based clinical protocols, either independent of primary care providers or with their approval, are more effective than merely providing information and adherence support to patients. Health systems will need to make decisions about team size, the number and type of team members, and team member roles that are best suited for their specific needs.
Providing patient support for participation in selfmanagement activities is vital. Support can range from educational resources on health behavior change to community-based peer support groups. This support could also be facilitated via various modalities for communication, such as mobile phones, smartphones, and patient web portals. 98 
Conclusions Summary of Findings
There is strong evidence that team-based care is effective in improving BP outcomes, especially when pharmacists and nurses are part of the team. These findings are broadly applicable to various U.S. settings and population groups. Further, an independent Community Guide review 99 of economic evidence indicates that teambased care for BP control is cost-effective. Implementation of this multidisciplinary team-based approach requires organizational change within the healthcare system.
Evidence Gaps
Although African Americans were well represented in included studies, more evidence is needed on team-based care for other minorities and low-SES populations. Included studies rarely analyzed outcomes by variables such as race, ethnicity, income level, education level, and insurance status. Further, patient-centered outcomes such as satisfaction with care and adherence to behavioral change activities need further study.
Regarding team composition, more studies are needed to evaluate team-based care models that incorporate other providers, such as community health workers and dietitians. Another vital aspect that was missing from most studies is information on the types of interactions between team members. Evidence on scalability of team-based care was sparse. More evidence is needed on the implementation of teambased care in large populations covering multiple sites and from multi-year evaluations.
Discussion
Team-based care is a complex intervention with considerable heterogeneity in implementation for different populations and settings. A formal meta-analysis was, therefore, not considered ideal for this review because sufficient homogeneity is required for meta-analysis estimates to be useful by themselves. 100 This review used descriptive statistics that facilitate simple and concise summaries of the distribution of study results. In addition, to be useful to public health decision makers, findings on the applicability of results to various U.S. populations and settings were based on stratified analyses, albeit in a univariate manner (Table 3) .
Although observational studies with concurrent comparison groups in addition to RCTs were included in this review, only five included studies employed an observational study design. The lack of observational studies in this review could limit understanding of team-based care in real-world settings, as well as barriers to implementation. Examination of a funnel plot suggests potential publication bias, with two of the largest studies reporting small improvements in the proportion of patients with controlled BP. However, this needs to be considered within the complex nature of team-based care implementation. Finally, the focus of this review was to assess the effectiveness of team-based care in preventing CVD from ever happening by controlling BP at the population level; therefore, populations with a history of CVD were excluded.
A recent evidence report 14 on team-based care for hypertension reached conclusions similar to this review: It called for teams of primary care providers, pharmacists, nurses, and other healthcare professionals to work with patients, especially in a medical home context. This push for coordinated care is furthered by the advent of accountable care organizations that operate on reimbursement models tied to quality metrics and targeting lower costs. 101 Team-based care is central to the medical home and accountable care approaches and can help health systems provide a method to improve the efficiency of care delivery, offer a platform of support for patient access to resources for self-management activities, and achieve a comprehensive approach to treating comorbidities such as hypertension, diabetes, high cholesterol, and obesity. In addition, team-based care can facilitate progress toward achieving the triple aim: improved health, a better care experience for patients, and reduced per capita costs. 102 A recent IOM report 103 explores both individual and organizational values behind successful teams in health care and calls for "investments in the people and processes that lead to improved outcomes." The Community Guide team attempted to collect information on strategies used to address potential barriers to implementation and increase motivation for team-based care. Strategies included involvement of providers in designing the intervention, stakeholder and patient engagement, basing implementation on "models of best practice" or "effective trials," putting business models in place, including reimbursement mechanisms and incentives, use of resources to implement team-based care (i.e., by restructuring existing resources or investment in new resources); making tools available for patients (e.g., websites) and providers (e.g., electronic health records); implementing motivational processes for team members (e.g., team-building sessions); and establishing systems to monitor and evaluate processes. Although available information on any of these elements was sparse in the included studies, it is crucial that these factors be considered by implementers of team-based care.
